Physician profile
Daniela Baumann
NPI 1982232146
$2,959.33
in general payments reported to CMS, 2019-2025
17 companies · $953 in 2025
The $953 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $86.11 · 2021: $711 · 2022: $734 · 2023: $313 · 2024: $163 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $616.14 | 2022-2025 | Envista Mx60 Iol, Infuse, Alden Scleral Zenlens |
| Alcon Vision LLC | $456.73 | 2022-2025 | Precision7, Clareon Panoptix Pro, Precision 1 |
| Coopervision INC. | $323.97 | 2024-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Dompe US, INC. | $299.70 | 2021-2025 | Oxervate |
| Oyster Point Pharma, INC. | $165.47 | 2022-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.24 | 2020-2021 | |
| Optos, INC. | $146.40 | 2021 | |
| Allergan, INC. | $137.73 | 2021 | |
| Eyevance Pharmaceuticals LLC | $130.85 | 2020-2023 | Flarex |
| Johnson & Johnson Vision Care, INC. | $127.52 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $118.87 | 2021 | |
| Thea Pharma INC. | $73.93 | 2022-2023 | Iyuzeh |
| Abbvie INC. | $64.39 | 2022 | |
| Akorn Operating Company LLC | $60.25 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $35.47 | 2023 | Lipiflow System Activator (Disposable) |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $31.21 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Baumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.